immunAware ApS: Financial statements 2022
CVR: 39189135
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
immunAware ApS (CVR 39189135) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,094,846 and a net result of DKK 1,567,432 compared with DKK 1,182,833 the year before. That is an increase of 48.6% compared with the year before. Equity in the 2022 report amounted to DKK 5,020,992. The solvency ratio was 92%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 5,094,846
- Profit/Loss
- DKK 1,567,432
- Equity
- DKK 5,020,992
- Total Assets
- DKK 5,456,419
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 5.1 mio. | 1.6 mio. | 5 mio. | 5 |
| 2021 | - | 3.4 mio. | 1.2 mio. | 3.6 mio. | 3 |
| 2020 | - | 2.4 mio. | 1.2 mio. | 2.6 mio. | 1 |
| 2019 | - | 2.3 mio. | 1.4 mio. | 1.5 mio. | 1 |
| 2018 | - | 25 t. | 19 t. | 151 t. | 0 |
Keep an eye on immunAware ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ImmunAware ApS has published its annual report for 2021. Gross profit came to DKK 3,427,889, and the net result was DKK 1,182,833.
About immunAware ApS
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.